Encephalopathy screening: Difference between revisions
Jump to navigation
Jump to search
(Created page with "{{Encephalopathy}} {{CMG}} ; {{AE}} {{ADI}} ==Overview== ==Screening== Screening helps in identification of impending encephalopathy or detection of subclinical encephalopa...") |
|||
| Line 6: | Line 6: | ||
==Screening== | ==Screening== | ||
Screening helps in identification of impending encephalopathy or detection of subclinical encephalopathy. Presently strategies for hepatic encephalopathy | Screening helps in identification of impending encephalopathy or detection of subclinical encephalopathy. Presently strategies for detecting subclinical hepatic encephalopathy and neonatal encephalopathy due to raised bilurubin levels exist. | ||
==References== | ==References== | ||
Revision as of 13:36, 20 July 2012
|
Encephalopathy |
|
Diagnosis |
|---|
|
Treatment |
|
Encephalopathy screening On the Web |
|
American Roentgen Ray Society Images of Encephalopathy screening |
|
Risk calculators and risk factors for Encephalopathy screening |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] ; Associate Editor(s)-in-Chief: Aditya Govindavarjhulla, M.B.B.S. [2]
Overview
Screening
Screening helps in identification of impending encephalopathy or detection of subclinical encephalopathy. Presently strategies for detecting subclinical hepatic encephalopathy and neonatal encephalopathy due to raised bilurubin levels exist.